证券代码：600821 证券简称：金开新能 公告编号：2025-50 金开新能源股份有限公司 第十一届董事会第九次会议决议公告 二、关于修订公司部分内部管理制度的议案 结合公司实际情况，根据《中华人民共和国公司法》《中华人民共和国证券 法》《上市公司章程指引》等法律、法规、规范性文件的规定，公司修订部分制 度，修订的制度包括：《关联交易管理制度》《信息披露管理制度》《内幕信息知 情人登记管理制度》《重大信息内部报告制度》《外部信息报送和使用管理制度》 《特定对象来访接待管理制度》《董事、高级管理人员持有和买卖公司股票管理 制度》《投资者关系管理制度》《债券募集资金管理制度》《债券信息披露管理办 法》。 具体内容详见公司于同日在上海证券交易所网站(www.sse.com.cn)披露的 相关制度。 表决结果：9 票同意、0 票反对、0 票弃权。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 金开新能源股份有限公司（以下简称"公司"）第十一届董事会第九次会议 通知于 2025 年 6 月 20 日以书面形式发出，会议于 2025 ...

Group 1 - Taotao Automotive expects a net profit of 310 million to 360 million yuan for the first half of 2025, representing a year-on-year increase of 70.34% to 97.81% [1] - The company specializes in the research, production, and sales of all-terrain vehicles, electric golf carts, electric scooters, electric balance bikes, electric bicycles, and their accessories [1] - China Communications Construction Company plans to repurchase shares worth between 500 million to 1 billion yuan, with a maximum repurchase price of 13.58 yuan per share [1][2] Group 2 - Annoqi's subsidiary received a government subsidy of 1.65 million yuan, accounting for 34.77% of the company's latest audited net profit [2] - Annoqi focuses on the research, production, and sales of mid-to-high-end differentiated dyes [3] - Minfeng Special Paper announced the complete shutdown of its Nanhu plant, as its Haiyan plant is now capable of handling the production capacity [4] Group 3 - Aoto Electronics received a trademark registration certificate from Saudi Arabia, covering various electronic products [5] - Landi Group plans to acquire up to 20.1667% of the shares of Jujia Technology for a total price not exceeding 121 million yuan [6][7] - Lifan Pharmaceutical's Danpi phenol raw material drug has been approved for market launch, utilizing a new process that enhances efficiency and meets market demand [8] Group 4 - Shanghai Construction received a total of 548 million yuan in government subsidies, which accounts for 22.79% of the company's latest audited net profit [8] - Wanbangde's subsidiary received ethical approval for a key clinical trial of a new drug for Alzheimer's disease [8] - Prolo Pharmaceutical's subsidiary received approval for the market launch of a new raw material drug for liver cancer treatment [9] Group 5 - Chenguang New Materials received a government subsidy of 26 million yuan, representing 62.86% of the company's latest audited net profit [10] - Sanyou Medical's subsidiary received a government subsidy of 331,000 yuan, accounting for 28.86% of the company's latest audited net profit [11] - Weichai Heavy Machinery expects a net profit of 132 million to 151 million yuan for the first half of 2025, reflecting a year-on-year increase of 40% to 60% [12] Group 6 - Guanhao Biological announced the termination of its application for a specific stock issuance [13] - China Film plans to use up to 1.5 billion yuan of idle funds for cash management [14] - Aotai Biological intends to use up to 480 million yuan of idle raised funds for cash management [15] Group 7 - Helin Micro-Nano is planning to issue overseas shares and list on the Hong Kong Stock Exchange [17] - Jinpan Technology's vice president resigned due to personal health reasons [18] - Tongyi Zhong's chairman and general manager plan to reduce their shareholdings in the company [19] Group 8 - Naipu Mining signed an overseas contract worth 18.85 million USD [21] - Zhengye Technology completed an asset sale transaction worth 178 million yuan [23] - Lianxin Equipment won a bid for a project worth 157 million yuan from BOE [24] Group 9 - Smart Control plans to apply for a comprehensive credit line of up to 260 million yuan from banks [25] - Keyuan Pharmaceutical's application for issuing shares to purchase assets has been accepted by the Shenzhen Stock Exchange [27] - Meige Intelligent's H-share listing application materials have been received by the China Securities Regulatory Commission [29] Group 10 - Siwei Tuxin's subsidiary submitted an H-share listing application [32] - Metro Design's application for issuing shares to purchase assets has been accepted by the Shenzhen Stock Exchange [32] - Aeston submitted an application for H-share listing [34] Group 11 - Jiu Ri New Materials' shareholders plan to reduce their holdings by a total of 98,900 shares [34] - Yihua Tong's shareholder plans to reduce their holdings by up to 700,000 shares [35] - Xishanghai plans to distribute a cash dividend of 0.08 yuan per share [36] Group 12 - Zhejiang Natural plans to distribute a cash dividend of 1.97 yuan for every 10 shares [37] - Kouzi Jiao plans to distribute a cash dividend of 1.30 yuan per share [38] - Huitong Group plans to distribute a cash dividend of 0.023 yuan per share [40] Group 13 - Tongyong Co. plans to reduce its holdings by up to 0.31% of the company's shares [41] - China Shenhua plans to distribute a cash dividend of 2.26 yuan for every 10 shares [43] - Huangting International's executive director resigned due to personal reasons [45] Group 14 - Jinkai New Energy plans to distribute a cash dividend of 1 yuan for every 10 shares [46] - Heimu Dan plans to distribute a cash dividend of 0.041 yuan per share [47] - Feiyada plans to acquire all or part of the controlling stake in Chang Kong Gear [48]

Core Points - The company announced a cash dividend of 0.1 yuan per share (including tax) for its A shares [1][2] - The profit distribution plan was approved at the annual general meeting on June 4, 2025 [2] - The total number of shares eligible for the dividend distribution is 1,967,324,953 shares after excluding 29,938,500 shares held in the company's repurchase account [2] Dividend Distribution Details - The cash dividend distribution will be based on the number of shares registered on the equity registration date, which is July 7, 2025 [1][2] - The last trading day is July 8, 2025, and the ex-dividend date is also July 8, 2025 [1][2] - The cash dividend will be distributed through the China Securities Depository and Clearing Corporation Limited Shanghai Branch [2] Taxation Information - For individual shareholders holding shares for more than one year, the dividend income is exempt from personal income tax [5] - For shares held for one year or less, the company will not withhold personal income tax at the time of distribution, but tax will be calculated upon the transfer of shares [5][6] - The actual cash dividend after tax for qualified foreign institutional investors (QFII) will be 0.09 yuan per share after a 10% withholding tax [6]

Group 1 - The company announced a voluntary share purchase plan by certain directors, senior management, and core employees, aiming to enhance quality, efficiency, and returns [1][2] - The total planned investment for the share purchase is no less than RMB 10.8 million, excluding transaction fees, with no set price range for the purchases [1] - As of June 27, 2025, a total of 1,269,500 shares have been purchased, amounting to RMB 6.9741 million, indicating that the plan is still ongoing [2] Group 2 - The share purchase includes contributions from key personnel, with the chairman acquiring 235,600 shares, representing 0.0118% of the total share capital [2] - Other notable purchases include 147,700 shares by the acting general manager and 107,600 shares by the financial officer, among others [2] - The company will continue to assess the implementation of the action plan and ensure compliance with relevant regulations during the share purchase process [3]

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、增持主体的基本情况 暨落实"提质增效重回报"行动方案的进展公告 金开新能源股份有限公司（以下简称"公司"）于 2025 年 4 月 30 日披露了 《金开新能源股份有限公司关于公司部分董事、高级管理人员及其他核心骨干员 工自愿增持公司股份计划暨落实"提质增效重回报"行动方案的公告》（公告编 号：2025-034），公司部分董事、高级管理人员及核心骨干员工计划自 2025 年 5 月 6 日起 6 个月内以自有资金通过上海证券交易系统允许的方式（包括但不限 于集中竞价、大宗交易）增持公司股份，拟增持合计不低于人民币 1,080 万元（含 交易费用）的公司 A 股股份，增持计划不设价格区间，将根据公司股票价格波动 情况及资本市场整体趋势逐步实施增持计划。 截至 2025 年 6 月 27 日，相关增持主体合计增持股份 1,269,500 股，增持金 额 697.41 万元，本次增持计划尚未实施完毕。 二、本次增持进展情况 证券代码：600821 证券简称：金开新能 公告编号：20 ...

l 型而事务所 YUAN LAW OFFICES 北京市嘉源律师事务所 关于金开新能源股份有限公司 差异化分红事项之 法律意见书 IIA YUAN LAW OFFICES 西城区复兴门内大街 158 号远洋大厦 4 楼 中国 · 北京 北京 BEIJING·上海 SHANGHAI·深圳 SHENZHEN·香港 HONGKONG·广州 GUANGZHOU·西安 XI`AN 致:金开新能源股份有限公司 北京市嘉源律师事务所 关于金开新能源股份有限公司 差异化分红事项之 法律意见书 嘉源(2025) -05-192 敬启者: 受金开新能源股份有限公司(以下简称"公司"或"金开新能")委托,北 京市嘉源律师事务所就公司 2024 年度利润分配涉及的差异化分红特殊除权除息 处理(以下简称"本次差异化分红")相关事项出具本法律意见书。 本法律意见书依据《中华人民共和国公司法》(以下简称"《公司法》")、 《中华人民共和国证券法》〈以下简称"《证券法》")、《上市公司股份回购 规则》（以下简称"《回购规则》"）、《上海证券交易所上市公司自律监管指 引第 7号 -- 回购股份》(以下简称"《回购股份指引》")、《上海证券交易 ...

证券代码：600821 证券简称：金开新能 公告编号：2025-049 金开新能源股份有限公司 关于完成工商变更登记并换发营业执照的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 金开新能源股份有限公司（以下简称"公司"）于 2025 年 5 月 9 日召开第 十一届董事会第八次会议，审议通过了《关于取消公司监事会并修订<公司章 程>及其附件的议案》。公司根据实际业务开展的需要，增加公司营业范围。上 述议案已经公司 2024 年年度股东大会审议通过。具体内容详见公司于 2025 年 5 月 10 日在上海证券交易所网站(www.sse.com.cn)披露的《关于取消公司监事 会并修订<公司章程>及其附件的公告》（公告编号：2025-037）。 公司于近日完成了工商变更登记和《公司章程》备案手续，并取得了天津 市和平区市场监督管理局换发的《营业执照》。公司根据工商部门的规范要求 调整了相应表述，变更后的经营范围及《公司章程》符合公司第十一届董事会 第八次会议和2024年年度股东大会所作决议内容。 件销售；智能输配电及控制设 ...

2024年年度权益分派实施公告 证券代码：600821 证券简称：金开新能 公告编号：2025-047 金开新能源股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 每股分配比例 A 股每股现金红利0.1元（含税） 相关日期 | 股份类别 | 股权登记日 | 最后交易日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | --- | --- | | Ａ股 | 2025/7/7 | － | 2025/7/8 | 2025/7/8 | 差异化分红送转： 是 一、通过分配方案的股东会届次和日期 本次利润分配方案经公司2025 年 6 月 4 日的2024年年度股东大会审议通过。 二、分配方案 1.发放年度：2024年年度 2.分派对象： 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任公司上海分 公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东。 根据《上海证券交易所上市公司自律监管指引第 7 号——回购股份》，公司通过回购专用 证券账户所持有的 ...

Core Viewpoint - The company is making a capital injection of up to 124,722.56 million RMB into its wholly-owned subsidiary, Jinkai Energy (Beijing) Energy Saving Technology Co., Ltd., to support its operational development and enhance its competitiveness [2][3][5]. Group 1: Investment Overview - The investment amount is capped at 124,722.56 million RMB, which will be used by the wholly-owned subsidiary, Jinkai Limited, to inject capital into Jinkai Energy [2][3]. - The capital injection has been approved by the company's general manager's office and does not require further approval from the board of directors or shareholders [3]. Group 2: Basic Information of the Investment Target - Jinkai Energy was established on May 16, 2025, and is located in Beijing [4]. - The company is a limited liability company with a registered capital of 1 million RMB and operates in areas such as energy management and renewable energy technology services [4]. Group 3: Impact of the Investment - The capital injection aims to enhance the subsidiary's operational capabilities and provide necessary support for project advancement, aligning with the company's strategic planning [5][6]. - The company's financial status is stable, and the use of self-owned funds for this investment will not adversely affect its normal operations or cash flow [6].

Group 1 - Beixin Road and Bridge's application for issuing shares to specific targets has been approved by the Shenzhen Stock Exchange, pending approval from the China Securities Regulatory Commission [1] - Wangbian Electric's shareholders plan to reduce their holdings by a total of up to 2.99% of the company's shares, with specific reductions detailed for each shareholder [1] - Guotou Zhonglu is planning a major asset restructuring, leading to a suspension of its stock trading for up to 10 trading days [2] Group 2 - Baiotai has signed a licensing agreement with SteinCares for the commercialization of BAT2406 in Brazil and Latin America, with total payments potentially reaching up to $10 million [3] - Dongfang Bio has obtained two medical device registration certificates for its products, which are valid until June 1, 2030 [4] - Pulaike's subsidiary has received a new veterinary drug registration certificate [5] Group 3 - Wanyi Technology has signed an agreement to establish a joint laboratory with the Energy Research Institute, with a total research and development budget of 6 million yuan [6] - Yingboer plans to use up to 300 million yuan of idle funds for financial management [7] - Blue Biological has received two new veterinary drug registration certificates [8] Group 4 - Jinkai New Energy intends to inject up to 1.247 billion yuan into its wholly-owned subsidiary to enhance its operational capabilities [9] - China Pacific Insurance's assistant general manager's qualification has been approved [10] - Zhaoyan New Drug is reducing its registered capital and notifying creditors [11] Group 5 - Weili Medical plans to invest 37.5 million yuan in establishing a medical industry investment fund [12] - Hongbai New Materials has signed a deposit agreement for idle raised funds [13] - Tongyou Technology is applying for a credit limit of 10 million yuan from a bank [14] Group 6 - Warner Pharmaceutical's subsidiary has received approval for its magnesium sulfate raw material drug [15] - Fuda Co. plans to establish a wholly-owned subsidiary with a capital contribution of 475 million yuan [16] - Yabao Pharmaceutical has obtained a loan commitment letter for stock repurchase of up to 90 million yuan [17] Group 7 - Zhongyin Securities' chairman has resigned due to work adjustments [18] - Aili Home has terminated its share reduction plan ahead of schedule [19] - Samsung New Materials has appointed a new financial officer [20] Group 8 - Guobang Pharmaceutical's subsidiary has received EU GMP certification for its product [21] - Yipin Hong has received a drug registration certificate for its injection solution [22] - Wenzhou Hongfeng's subsidiary has obtained a utility model patent certificate [23] Group 9 - Cangge Mining plans to sign a financial service agreement with Zijin Mining Group [24] - Naipu Mining's application for convertible bonds has been accepted by the Shenzhen Stock Exchange [25] - Shenyang Machine Tool has completed its major asset restructuring [26] Group 10 - Xinlaifu plans to distribute a cash dividend of 5 yuan per 10 shares [27] - Jiashitang plans to distribute a cash dividend of 1.7 yuan per 10 shares [28] - Manbuer plans to distribute a cash dividend of 2.5 yuan per 10 shares [29] Group 11 - Guo Wang Yingda plans to distribute a cash dividend of 0.51 yuan per 10 shares [30] - Changsha Bank's shareholder plans to reduce holdings by up to 0.92% [31] - Hu Nong Commercial Bank plans to distribute a cash dividend of 1.93 yuan per 10 shares [32] Group 12 - Huaxiang Co. plans to distribute a cash dividend of 1.17 yuan per 10 shares [33]